OPKO Health, Inc. (OPK) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

OPKO Health, Inc. (OPK) closed at USD 1.37 on 2026-10-14, a change of -4.9 % over the past year, with a market capitalization of USD 1.2B.

OPKO Health, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

OPKO Health, Inc. key figures

Previous close

USD 1.37 (2026-10-14)

1-year change

-4.9 %

Market cap

USD 1.2B

Enterprise value

USD 1.3B

P/E ratio (trailing)

-14.64

P/E ratio (forward)

-5.96

EPS (trailing)

-0.11

EPS (forward)

-0.27

PEG ratio

93.65

Price to book

1.01

Revenue growth

4.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

12.42

Employees

2,275

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About OPKO Health, Inc.

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for OPKO Health, Inc. and compare it with other stocks.